Managing type 2 diabetes needs a paradigm change.

Narayan, K M Venkat; Jagannathan, Ram; Ridderstråle, Martin

Narayan, K M Venkat; Jagannathan, Ram; Ridderstråle, Martin.

Afiliação

Narayan KMV; Emory Global Diabetes Research Center of Woodruff Health Sciences Center, Rollins School of Public Health Emory University, Atlanta, GA, USA; School of Medicine, Emory University, Atlanta, GA, USA. Electronic address: knaraya@emory.edu.
Jagannathan R; Emory Global Diabetes Research Center of Woodruff Health Sciences Center, Rollins School of Public Health Emory University, Atlanta, GA, USA.
Ridderstråle M; Department of Clinical Sciences, Lund University, Malmö, Sweden; The Novo Nordisk Foundation, Hellerup, Department of Clinical Sciences, Lund University, Malmö, Sweden; The Novo Nordisk Foundation, Hellerup, Denmark, Denmark.

Lancet Diabetes Endocrinol ; 11(8): 534-536, 2023 08.

Article em En | MEDLINE | ID: mdl-37385288

Assuntos

Diabetes Mellitus Tipo 2; Humanos; Diabetes Mellitus Tipo 2/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google